Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
EA
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.2% |
| 2 | Technology | 14.19% |
| 3 | Financials | 12.33% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
2176
DELISTED
Endo International plc
ENDP
| $2.31M | ﹤0.01% |
+206,500
| New | +$2.42M |
|
|
RBPAA
2177
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
| $2.31M | ﹤0.01% |
545,082
+85,665
| +19% | +$354K |
|
2178
BK Technologies
BKTI
$277M
| $2.3M | ﹤0.01% |
122,803
+4,063
| +3% | +$93.4K |
|
2179
AmeriServ Financial
ASRV
$85.5M
| $2.3M | ﹤0.01% |
554,647
+69,947
| +14% | +$281K |
|
|
MGCD
2180
DELISTED
MGC Diagnostics Corporation
MGCD
| $2.3M | ﹤0.01% |
280,645
+8,005
| +3% | +$65.9K |
|
|
SHLO
2181
DELISTED
Shiloh Industries Inc
SHLO
| $2.3M | ﹤0.01% |
195,900
+46,200
| +31% | +$577K |
|
2182
ONE Gas
OGS
$5.08B
| $2.3M | ﹤0.01% |
32,900
-29,600
| -47% | -$2.06M |
|
|
DFRG
2183
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $2.3M | ﹤0.01% |
142,589
+98,289
| +222% | +$1.69M |
|
2184
Lincoln Educational Services
LINC
$919M
| $2.29M | ﹤0.01% |
739,100
+92,419
| +14% | +$284K |
|
|
RLH
2185
DELISTED
Red Lions Hotel Corporation
RLH
| $2.29M | ﹤0.01% |
311,700
-53,600
| -15% | -$354K |
|
2186
Farmers National Banc Corp
FMNB
$964M
| $2.29M | ﹤0.01% |
157,900
+20,200
| +15% | +$284K |
|
2187
Tredegar Corp
TG
$274M
| $2.28M | ﹤0.01% |
149,545
+65,745
| +78% | +$1.07M |
|
|
CORE
2188
DELISTED
Core Mark Holding Co., Inc.
CORE
| $2.28M | ﹤0.01% |
68,900
-111,900
| -62% | -$3.8M |
|
2189
Stagwell
STGW
$2.25B
| $2.27M | ﹤0.01% |
229,700
+41,700
| +22% | +$360K |
|
2190
AMC Global Media
AMCX
$503M
| $2.27M | ﹤0.01% |
42,500
-293,700
| -87% | -$16.4M |
|
2191
Ceco Environmental
CECO
$4.57B
| $2.27M | ﹤0.01% |
246,983
-118,000
| -32% | -$1.19M |
|
2192
PAR Technology
PAR
$777M
| $2.27M | ﹤0.01% |
266,400
+68,000
| +34% | +$567K |
|
|
TGA
2193
DELISTED
Transglobe Energy Corp
TGA
| $2.26M | ﹤0.01% |
1,687,700
+66,300
| +4% | +$96.6K |
|
|
KONA
2194
DELISTED
Kona Grill, Inc.
KONA
| $2.26M | ﹤0.01% |
611,159
+182,100
| +42% | +$836K |
|
|
TREC
2195
DELISTED
Trecora Resources
TREC
| $2.26M | ﹤0.01% |
200,900
-48,600
| -19% | -$544K |
|
2196
Triumph Financial Inc
TFIN
$1.87B
| $2.26M | ﹤0.01% |
91,900
-59,912
| -39% | -$1.39M |
|
2197
CEMIG Preferred Shares
CIG
$5.55B
| $2.25M | ﹤0.01% |
+1,842,060
| New | +$2.44M |
|
2198
National CineMedia
NCMI
$262M
| $2.25M | ﹤0.01% |
30,370
-54,540
| -64% | -$5.09M |
|
|
ALTA
2199
DELISTED
Altabancorp
ALTA
| $2.25M | ﹤0.01% |
84,085
+20,085
| +31% | +$527K |
|
|
VYNT
2200
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $2.25M | ﹤0.01% |
3,798
+801
| +27% | +$468K |
|
Similar funds
Jim Simons's Q2 2017 Portfolio in Review
As of Q2 2017, Jim Simons held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Jim Simons deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Jim Simons's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Jim Simons added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Jim Simons's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Jim Simons fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Jim Simons's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Jim Simons opened 398 new positions and closed 418 in Q2 2017.
- Jim Simons's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.